Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SCP.WAthis companyScope Fluidics S.A.	PLN 142.80	-8.13×	2.32×	3,770.02×	-6.68×	-79.6%	-44395.0%	-47227.0%	-46364.0%	-28.5%	-25.6%	-12.6%	0.11×	1.68×	-240.95×	13.06×	0.0%	1	8.08	2	C
BCX.WABioceltix S.a.	PLN 68.70	-25.61×	5.29×	0×	-19.22×	-79.7%	0.0%	0.0%	0.0%	-20.7%	-23.5%	-3.6%	0×	4.09×	-82.9×	32.51×	0.0%	2	70.81	2	C
BIO.WABioton S.a.	PLN 3.49	97.72×	0.56×	1.17×	7.42×	-205.5%	34.2%	4.5%	1.2%	0.6%	0.8%	0.7%	0.1×	0.95×	2.19×	1.41×	0.0%	4	-0.67	3	B
BMX.WABioMaxima S.A.	PLN 8.60	482×	1.05×	0.83×	17.71×	-109.3%	2.7%	-0.2%	0.2%	0.2%	-0.1%	2.6%	0.3×	3.56×	-0.11×	1.74×	0.0%	8	2.25	2	B-
CTX.WACaptor Therapeutics Spolka Akcyjna	PLN 53.20	-9.46×	16.92×	85.26×	-7.99×	-150.3%	-14.0%	-1141.8%	-901.2%	-178.9%	-195.8%	-9.2%	0.15×	0.15×	-188.01×	2.27×	0.0%	2	7.35	1	C-
ENE.WACentrum Medyczne ENEL-MED S.A.	PLN 20.00	37.39×	2.62×	0.57×	7.78×	354.0%	9.3%	2.4%	1.5%	6.9%	3.0%	4.5%	1.84×	3.02×	2×	0.6×	0.0%	6	2.29	3	B
Peer median	—	37.39×	2.62×	0.83×	7.42×	-109.3%	2.7%	0.0%	0.2%	0.2%	-0.1%	0.7%	0.15×	3.02×	-0.11×	1.74×	0.0%	4	2.29	2	—